Akshaya Rathin Sivaji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akshaya Rathin Sivaji has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Jun Tae Park
Epilepsy Center, Neurological Institute, UH Cleveland Medical Center, Cleveland, OH, USA
2 shared publications - Neel Fotedar
Epilepsy Center, Neurological Institute University Hospitals Cleveland Medical Center Cleveland Ohio USA
2 shared publications - A. Marian Jude Vijay
Department of Neurology, Madras Medical College, Chennai, Tamil Nadu, India
1 shared publication - Adina Chirla
UH Rainbow Babies & Children's Hospital, Cleveland, OH, USA
1 shared publication - Alexander Namrow
Department of Pediatrics, UH Rainbow Babies & Children's Hospital, Cleveland, OH, USA
1 shared publication Guadalupe Fernandez‐BacaVaca
Epilepsy Center, Neurological Institute University Hospitals Cleveland Medical Center Cleveland Ohio USA
1 shared publication
Latest Publications
- 3 March 2026
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 41 (7) , 1006-1010
Electrophysiological and Quantitative Fingerprints of Landau-Kleffner Syndrome
- 3 March 2026
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 41 (7) , 1006-1010
Electrophysiological and Quantitative Fingerprints of Landau-Kleffner Syndrome
- 5 January 2026
- Published by Wiley in Epileptic Disorders
- Vol. 28 (2) , 559-561
EEG and surface‐electromyography correlate of tonic seizures in supplementary sensorimotor area epilepsy
- 5 January 2026
- Published by Wiley in Epileptic Disorders
- Vol. 28 (2) , 559-561
EEG and surface‐electromyography correlate of tonic seizures in supplementary sensorimotor area epilepsy
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 15 (6) , e200559
Localizing and Lateralizing Significance of Initial, Mid-Ictal, and Ictal-End Head Position in Versive Seizures With Secondary Generalization
The aim of this study was to assess the localizing and lateralizing significance of initial, mid-ictal, and ictal-end head position in versive seizures with secondary generalization. We analyzed video-EEG recordings of 65 patients with focal epilepsy for various head position changes during version evolving into secondary generalized tonic-clonic (GTC) seizure. We calculated the latency of version from seizure onset and the latency of secondary generalization from version. We excluded patients with generalized epilepsy. The latency of version from seizure onset (T1) was 46.7 ± 8.8 sec and 24.1 ± 8.2 sec in temporal and frontal lobe groups, respectively (p < 0.0001). Occipital seizures had the longest latency of 77.8 ± 42.9 sec (p = 0.0002). The latency of secondary GTC seizures (T4) from initial version was 15.7 ± 3.2 sec in the temporal lobe group, compared with 18.3 ± 5.7 sec in the frontal lobe group (p = 0.03) and 18.8 ± 9.3 sec (p = 0.13) in the parietal lobe group. Occipital seizures had the shortest latency at 9.8 ± 3.9 sec (p = 0.0001). In 57 of 65 patients, the head position evolved to a primary midline position from the initial version. In 24 of 65 patients, the head position further evolved to an ictal-end position by the end of the GTC phase. In these 24 patients, the ictal-end head position was contralateral to the direction of initial version in 100% of cases, and hence ipsilateral to the epileptogenic zone. In total, 13 of these 24 patients also had corresponding ipsilateral ictal-end clonic movement. Latency of onset of the initial version has a localizing significance for the epileptogenic zone, with the shortest latency for frontal seizures and the longest for occipital seizures. This is consistent with the relative distance of the frontal eye field from these seizure-onset zones. An ictal-end head position contralateral to the initial version occurs in approximately 37% of focal epilepsies and is always ipsilateral to the epileptogenic zone.
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 15 (6) , e200559
Localizing and Lateralizing Significance of Initial, Mid-Ictal, and Ictal-End Head Position in Versive Seizures With Secondary Generalization
The aim of this study was to assess the localizing and lateralizing significance of initial, mid-ictal, and ictal-end head position in versive seizures with secondary generalization. We analyzed video-EEG recordings of 65 patients with focal epilepsy for various head position changes during version evolving into secondary generalized tonic-clonic (GTC) seizure. We calculated the latency of version from seizure onset and the latency of secondary generalization from version. We excluded patients with generalized epilepsy. The latency of version from seizure onset (T1) was 46.7 ± 8.8 sec and 24.1 ± 8.2 sec in temporal and frontal lobe groups, respectively (p < 0.0001). Occipital seizures had the longest latency of 77.8 ± 42.9 sec (p = 0.0002). The latency of secondary GTC seizures (T4) from initial version was 15.7 ± 3.2 sec in the temporal lobe group, compared with 18.3 ± 5.7 sec in the frontal lobe group (p = 0.03) and 18.8 ± 9.3 sec (p = 0.13) in the parietal lobe group. Occipital seizures had the shortest latency at 9.8 ± 3.9 sec (p = 0.0001). In 57 of 65 patients, the head position evolved to a primary midline position from the initial version. In 24 of 65 patients, the head position further evolved to an ictal-end position by the end of the GTC phase. In these 24 patients, the ictal-end head position was contralateral to the direction of initial version in 100% of cases, and hence ipsilateral to the epileptogenic zone. In total, 13 of these 24 patients also had corresponding ipsilateral ictal-end clonic movement. Latency of onset of the initial version has a localizing significance for the epileptogenic zone, with the shortest latency for frontal seizures and the longest for occipital seizures. This is consistent with the relative distance of the frontal eye field from these seizure-onset zones. An ictal-end head position contralateral to the initial version occurs in approximately 37% of focal epilepsies and is always ipsilateral to the epileptogenic zone.
- 13 May 2025
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 40 (8) , 669-671
Ethosuximide Induced Raynaud's Phenomenon in a Child With Childhood Absence Epilepsy
- 13 May 2025
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 40 (8) , 669-671
Ethosuximide Induced Raynaud's Phenomenon in a Child With Childhood Absence Epilepsy
- 28 April 2021
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 9 (5) , 1301-1305
A study on prevalence of various mood disorders in patients with multiple sclerosis in South Indian population Chennai, Tamil Nadu
Background: The prevalence of depressive disorders are more common in demyelination diseases like multiple sclerosis. Patients with multiple sclerosis have higher rates of depressive episodes than the general population. It is found that 40-50% incidence reported in many number of previous research studies .The aim is to study the prevalence of various depressive disorders in multiple sclerosis (MS) patient population.Methods: 176 MS patients were randomly selected from neurology outpatient department (OPD) of Tamil Nadu Government Multi Super Specialty Hospital and Rajiv Gandhi Government General Hospital, Chennai, Tamil Nadu, from September 2018 to December 2019. 128 patients were analyzed with the following methods of examinations such as the structured psychiatric clinical interview with diagnostic and statistical manual of mental disorders (DSM)-5 and international classification of diseases (ICD)-10 criteria, Hamilton depression rating scale (HAM-D) scale.Results: Various subtypes of mood disorders were found as follows major depressive disorder (MDD)-4%, MDD with anxiety-6%, pervasive developmental disorders (PDD) mixed-4%, premenstrual dysphoric disorder (PMDD)-8%, MIDD-2% and depressive disorders due to general medical conditions (secondary depression)-22%. In this present study 46% of the MS population were diagnosed with various depressive illness.Conclusions: Early identification and treatment of depressive disorders definitely favour the outcome of MS patients. The coping skills and good social support system play a vital role in the outcome of depressive disorders in MS population in addition to psychopharmacological management.
- 28 April 2021
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 9 (5) , 1301-1305
A study on prevalence of various mood disorders in patients with multiple sclerosis in South Indian population Chennai, Tamil Nadu
Background: The prevalence of depressive disorders are more common in demyelination diseases like multiple sclerosis. Patients with multiple sclerosis have higher rates of depressive episodes than the general population. It is found that 40-50% incidence reported in many number of previous research studies .The aim is to study the prevalence of various depressive disorders in multiple sclerosis (MS) patient population.Methods: 176 MS patients were randomly selected from neurology outpatient department (OPD) of Tamil Nadu Government Multi Super Specialty Hospital and Rajiv Gandhi Government General Hospital, Chennai, Tamil Nadu, from September 2018 to December 2019. 128 patients were analyzed with the following methods of examinations such as the structured psychiatric clinical interview with diagnostic and statistical manual of mental disorders (DSM)-5 and international classification of diseases (ICD)-10 criteria, Hamilton depression rating scale (HAM-D) scale.Results: Various subtypes of mood disorders were found as follows major depressive disorder (MDD)-4%, MDD with anxiety-6%, pervasive developmental disorders (PDD) mixed-4%, premenstrual dysphoric disorder (PMDD)-8%, MIDD-2% and depressive disorders due to general medical conditions (secondary depression)-22%. In this present study 46% of the MS population were diagnosed with various depressive illness.Conclusions: Early identification and treatment of depressive disorders definitely favour the outcome of MS patients. The coping skills and good social support system play a vital role in the outcome of depressive disorders in MS population in addition to psychopharmacological management.